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UM SPIN-OFF COMPANY INVESTIGATES
CHEMICAL NERVE AGENTS, NEW DRUGS "
MISSOULA -
University of Montana researcher Chuck Thompson and his partners have started a 
biotechnology company that soon may offer diagnostic tools for fighting terrorism. The 
company is called ATERIS.
“It’s an acronym for antibodies, transporters, enzymes, receptors, inhibitors and 
substrates,” Thompson said with a smile. “It’s kind of a nerd approach to naming, but those 
are the six things we work w ith.” >
ATERIS workers also will work to invent new small-molecule drugs and uncover 
methods to inactivate proteins responsible for certain diseases.
Thompson and Jon Nagy, an independent scientist from Bozeman, are working on a 
flat, card-like film that changes color in the presence of chemical nerve agents. He said it will 
operate somewhat like a home pregnancy test.
The scientists have been awarded a $2.3 million Small Business Innovation Research 
grant from the National Institutes of Health to launch their idea. Thompson said it’s a 
prestigious amount since SBIR awards are generally given in phases — with Phase I offering
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about $100,000 to explore the feasibility of projects -  but their proposal earned the equivalent 
of two phases in one attempt.
Thompson said ATERIS will initially employ eight people, including UM cellular 
biochemist Katie George, who was a co-investigator on the grant proposal. He hopes to hire 
UM students and take advantage of the University’s resources, technology and infrastructure 
for the new company. And since Nagy has a laboratory in Bozeman, the firm initially will be 
housed in both Missoula and Bozeman.
In a chemical attack, such as the 1995 sarin nerve gas incident on a Tokyo subway, 
chemical agents attach themselves to proteins in body fluids such as blood, creating a unique 
signature ATERIS scientists hope to detect.
“So what we are trying to do with our prototype is develop a film that if you took a 
blood sample, a saliva sample or urine sample, it could detect that you have been exposed by 
changing colors,” Thompson said. “It could be as simple as saying, ‘Here lick this.’”
He said their test would unequivocally identify whether an exposure event had taken 
place, because the only way your body would contain the modified proteins is if it had been 
exposed to a chemical agent.
They hope to design a film that will quantify how much of the protein was formed in 
response to the nerve agent. This would allow health care providers to rapidly tell whether you 
could be helped by therapeutic intervention or not.
Thompson said the technology eventually could be applied to all manner of chemical 
exposures, not just chemical nerve agents.
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“It could tell if we’ve inhaled too much paint or stepped on too much fertilizer on the 
farm,” he said. “I mean, it could tell you anything so long as the protein was modified.”
Thompson met Nagy while they scientific interns from 1983 to 1985 at The University 
of California, Berkeley. The lab partners became friends and by chance both moved to 
Montana to pursuer their careers.
Thompson joined UM ’s chemistry department in 1995 and later transferred to the 
Department of Biomedical and Pharmaceutical Sciences, where he is a professor of medical 
chemistry and a member of Center for Structural and Functional Neuroscience.
He also directs the National Science Foundation’s Experimental Program to Stimulate 
Competitive Research in Montana, which works to boost Big Sky science and stimulate the 
state’s economy.
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